DPT-17250-27657
3 vaccinations
5 coded responses
38 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Registered in v-safe
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-05-07
Dose 2 — Pfizer-BioNTech
- 2021-05-07
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-21
- 2021-05-30
- 2021-06-06
-
2021-06-11
Survey response — day 35, dose 2MedDRA: Sinus headache — Feeling: PoorFree text: Sinus headachMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-18
- 2021-08-06
-
2021-11-07
Survey response — 6 months, dose 2MedDRA: Chills, Cough, Pain, Pyrexia, Rhinorrhoea, Vomiting — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fever of 101.6, body aches, chills, runny nose, coughing, vomitingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Dose 3 — Pfizer-BioNTech
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
-
2021-12-20
Survey response — day 14, dose 3MedDRA: Hand-foot-and-mouth disease — Feeling: FairFree text: Hand foot & mouth diseaseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-28
- 2022-01-03
-
2022-01-11
Survey response — day 35, dose 3MedDRA: Pre-existing disease, Rhinorrhoea — Feeling: GoodFree text: Slight runny nose, could be from indoor allergiesMedDRA releases: 2024-11 · check-in free text available
- 2022-01-17
- 2022-03-07
-
2022-06-06
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: PoorFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Pfizer-BioNTech | No |
Free text
Release 9 — day 35, dose 2
Symptoms: Sinus headach
Release 10 — 6 months, dose 2
Symptoms: Fever of 101.6, body aches, chills, runny nose, coughing, vomiting
Release 10 — day 14, dose 3
Symptoms: Hand foot & mouth disease
Release 10 — day 35, dose 3
Symptoms: Slight runny nose, could be from indoor allergies
Release 11 — 6 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus headache | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release